Multiple studies have confirmed that six drugs, including liraglutide and semaglutide, have all demonstrated significant dose-dependent weight loss effects [59]
Some people maintain their results, while others regain weight, especially if healthy habits arent in place
If youre taking ACE inhibitors or ARBs, the combined effect on your kidneys requires careful specialist monitoring
5 Clinical evidence at each dose Wegovy: the STEP 1 trial The STEP 1 trial published in the New England Journal of Medicine tested semaglutide 2.4 mg in 1,961 adults with obesity (without diabetes) over 68 weeks
it remains to be seen how it will fare in the current Congress
Abrupt discontinuation is generally not recommended, and autoimmune patients should have a plan for monitoring disease activity during and after the weaning process